Knowledge HQ

All
Videos

Ignacio Núñez, COO, CellReady, Discusses Partnership with ScaleReady at ISCT 2024

Rizwan Chaudrey spoke with Ignacio Núñez, COO, CellReady, at ISCT 2024  about the company, its relationship with ScaleReady, what they are showcasing tat ISCT and what makes them unique.
Watch Video
Literature

ExCellerateTM T Cell Media Animal Component-Free Flyer

ExCellerate T Cell Media supports robust ex vivo CD3+ T cells, while maintaining high viability. This media is optimized to be used with Bio-Techne R&D SystemsTM cytokines and is compatible Excellerate media is compatible with closed system G-Rex bioreactors.
Download Now
Application Notes

Avectas Solupore® and G-Rex® Platform App Note

In this application, the health of Triple Knock-Out (KO) transfected T-cells was evaluated by measuring cell expansion and viability in a Gas Permeable Rapid Expansion (G-Rex® - Wilson Wolf Manufacturing, LLC) platform using different cell culture media and cytokine supplement.

Download Now
Literature

G-Rex Grant Program Flyer

The G-Rex® Grant Program is empowering CGT manufacturers with resources and expertise and is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).  If you’re engaged in pre-clinical research, process development, or cGMP manufacturing of cell and gene-modified cell therapies, this program is for you!
View Flyer
Literature

G-Rex Grant Program Outline

Review the official description and outline of the new G-Rex® Grant Program, which empowers CGT manufacturers with resources and expertise. This $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady is designed to propel the advancement of cell and gene therapies (CGT).
Read More
Videos

Multiply Labs and Wilson Wolf Collaborate to Automate G-Rex for Cell Therapy Manufacturing

Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Wilson Wolf, an innovative leader in cell and gene-modified cell (CGT) manufacturing technology, today announced a collaboration around the automation of Wilson Wolf’s G-Rex® bioreactors.

Watch Video
Scientific Posters

AgonOx Cell Therapy Manufacturing Process Scientific Poster

To better optimize their manufacturing process for a current clinical trial and IND amendment, AgonOx and Providence began to look for products to close and streamline key portions of the established manufacturing process for a shared project. It was imperative to find products that would maintain established levels of cell recovery, viability, and efficacy.
Review Poster
Application Notes

Analytical Tools to Evaluate CAR-T Cell Signaling & Activation App Note

CAR-T cell therapy has emerged as a powerful weapon in the fight against specific B-cell malignancies. Its success has fueled significant research efforts to broaden its reach to encompass a wider range of hematologic and solid tumors.  Optimizing CAR-T cell therapy hinges on a deeper understanding of the intricate signaling pathways that govern these potent immune cells. This includes their ability to infiltrate tumors, evade antigen escape mechanisms, resist immunosuppression, and minimize potentially fatal toxicities. To achieve this, researchers require a comprehensive characterization of the signaling molecules involved, encompassing the extracellular, membrane-bound, and intracellular compartments. However, this endeavor is often hampered by limited and complex sample types.  The Wilson Wolf G-Rex platform offers a unique solution for large-scale expansion of CAR-T cells, enabling researchers to study these vital communication networks within larger, more robust cell populations. This facilitates a deeper understanding of CAR-T cell function and paves the way for the development of safer and more effective CAR-T therapies.  Unleash the Full Potential of CAR-T Cells: Learn More Understanding these vital communication networks within CAR-T cells is critical to unlocking their full potential. Download our free App Note: Analytical Tools to Evaluate CAR-T Cell Signaling & Activation to explore the latest advancements in research methods for optimizing CAR-T cell therapy. 
Download Now
Case Studies

G-Rex: Expanding the Capabilities of Scalability

When global events affected the availability of products used in the manufacture of cell therapies, teams needed to explore alternative manufacturing methods. This supply chain crisis emphasized the need to establish redundant processes to address production obstacles for critical stages of cell therapy manufacturing.
Download Now
Scientific Posters

TcBuster transposase for robust delivery of multicistronic therapeutic cargo - Scientific Poster

TcBuster-MTM (TcB-MTM) is a commercially available non-viral transposase-based editing platform that overcomes current viral limitations. TcBuster is found in the red flour beetle and is a member of the hAT family of transposases. Using directed evolution, we engineered a hyperactive mutant (TcB-M) that has improved transposition rates using less mRNA transposase and NanoplasmidTM DNA transposon.
View Poster
Scientific Posters

Feeder-Free Human iNK Differentiation Process - Scientific Poster

Current iNK differentiation protocols typically utilize xenogenic feeder cells, which could be problematic for patient safety, or they lack robustness and are highly variable in differentiation efficiency. Using animal-free small molecules and recombinant proteins, Bio-Techne developed a feeder-free differentiation process to reliably generate iNKs at scale by optimizing for CD34+ hematopoietic stem cells (iHSC) prior to downstream NK differentiation.

View Poster
Protocols

ExCellerate NK Media Feeder-Cell G-Rex Culture Process

Download the ExCellerate NK Media Feeder-Cell G-Rex Culture Process
Download

ScaleReady is a joint venture between Wilson Wolf Manufacturing and Bio-Techne.